Latest Conference Articles

Managing Vasomotor Symptoms of Menopause: A Topline Comparison of Treatments

Managing Vasomotor Symptoms of Menopause: A Topline Comparison of Treatments

May 13th 2025

ACOG

Medical and nonpharmacologic treatment options for VMS range in efficacy and risk/benefit profile; a short slide show offers a topline look at how many compare.

Vasomotor Symptoms of Menopause: Facts At-a-Glance for Primary Care

Vasomotor Symptoms of Menopause: Facts At-a-Glance for Primary Care

May 13th 2025

ACOG

Hot flashes and night sweats are just 2 of the myriad symptoms associated with menopause. Click through a quick refresher on the transition and effective treatments.

Foluso Fakorede, MD: Racial Disparities in PAD Amputation Rates

Foluso Fakorede, MD: Racial Disparities in PAD Amputation Rates

May 6th 2025

ACP

Rates of amputation in Black Americans with peripheral arterial disease are 3-times higher than that of their White counterparts. Dr Fakorede, discusses, here.

PAD Risk Amplifiers and Screening Strategies: A Talk with Foluso Fakorede, MD

PAD Risk Amplifiers and Screening Strategies: A Talk with Foluso Fakorede, MD

May 2nd 2025

ACP

ACP 2025: Dr Fakorede outlines PAD risk amplifiers, polyvascular disease connections, and when to screen using ABI, TBI, or exercise testing in high-risk patients.

Peripheral Artery Disease in Primary Care: Expert Insights on Recognition & Risk Factors

Peripheral Artery Disease in Primary Care: Expert Insights on Recognition & Risk Factors

May 1st 2025

ACP

ACP 2025: Foluso Fakorede, MD, discusses the importance of recognizing and screening for peripheral artery disease in primary care.

Clinical Pearls from 2025 ACP Internal Medicine Meeting

Clinical Pearls from 2025 ACP Internal Medicine Meeting

April 28th 2025

ACP

Expert insights on PAD prevention, boosting colon cancer screening, and expanding obesity treatment options.

Postpartum Hormonal Contraceptive Use Linked to Increased Risk of Depression

Postpartum Hormonal Contraceptive Use Linked to Increased Risk of Depression

April 25th 2025

ACOG

The increased risk of depression when oral contraceptives were started following childbirth was "instantaneous," researchers wrote, and was ~50% greater than nonuse.

The Role for CGM in Glycemic Management Will Continue to Expand, Including in Prediabetes, Expert Says

The Role for CGM in Glycemic Management Will Continue to Expand, Including in Prediabetes, Expert Says

April 25th 2025

ACP

CGM is now standard of care in T1D and evidence is solid for a role in insulin-treated T2D; Thomas Martens, MD, shares thoughts on CGM growth in the next 3-5 years.

How to Maximize CGM Data Presented in the Ambulatory Glucose Profile: Thomas Martens, MD, Illustrates

How to Maximize CGM Data Presented in the Ambulatory Glucose Profile: Thomas Martens, MD, Illustrates

April 24th 2025

ACP

Martens, medical director of the International Diabetes Center (IDC) in Minneapolis, highlights an IDC resource that helps target problem areas in management of hyperglycemia.

Intermittent and Continuous Glucose Monitoring: Thomas Martens, MD, Details the Differences

Intermittent and Continuous Glucose Monitoring: Thomas Martens, MD, Details the Differences

April 23rd 2025

ACP

Martens, Director of the International Diabetes Center, in Minneapolis, highlights the differences between the 2 methods and what the research has found on each.